Multicriteria Decision Analysis (MCDA) In HTA - Pilot Study in the Czech Republic.

Hajek, P; Pecen, L; Bulejova, L; Cook, M; Dolezal, T; Dolezel, J; Duba, J; Dukova, I; Fuksa, L; Heislerova, M; Jaskova, K; Karasek, P; Klimes, J; Kminek, A; Kucera, Z; Vesela, S; Vothova, P; Svihovec, J

Hajek, P; Pecen, L; Bulejova, L; Cook, M; Dolezal, T; Dolezel, J; Duba, J; Dukova, I; Fuksa, L; Heislerova, M; Jaskova, K; Karasek, P; Klimes, J; Kminek, A; Kucera, Z; Vesela, S; Vothova, P; Svihovec, J.

Afiliación

Hajek P; Pfizer s r. o., Prague, Czech Republic.
Pecen L; CEEOR s. r. o., Prague, Czech Republic.
Bulejova L; InterMune, Muttenz, Switzerland.
Cook M; BAYER s. r. o., Prague, Czech Republic.
Dolezal T; VALUE OUTCOMES, Prague, Czech Republic.
Dolezel J; GlaxoSmithKline, s. r. o., Prague, Czech Republic.
Duba J; OAKS Consulting s. r. o., Prague 9, Czech Republic.
Dukova I; Merck, Prague, Czech Republic.
Fuksa L; General Health Insurance Company of the Czech Republic, Praha, Czech Republic.
Heislerova M; University Hospital in Motol, Prague, Czech Republic.
Jaskova K; Merck, Prague, Czech Republic.
Karasek P; Novartis s. r. o., Prague, Czech Republic.
Klimes J; iHETA, Prague, Czech Republic.
Kminek A; AstraZeneca, Prague, Czech Republic.
Kucera Z; Sanofi-Aventis, Prague, Czech Republic.
Vesela S; Janssen, Prague, Czech Republic.
Vothova P; Pfizer s r. o., Prague, Czech Republic.
Svihovec J; University Hospital in Motol, Prague, Czech Republic.

Value Health ; 17(7): A439, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27201174

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Health_technology_assessment Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google